Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Current Problems in Cancer|October 28, 2021
<sup>18</sup>F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastasesKalevi Kairemo, Jason Roszik, Pete Anderson, et al.
Plos One|April 16, 2011
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signaturesVivek Subbiah, Aung Naing, Robert E Brown, et al.
Journal of Pediatric Surgery|August 21, 2007
Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumorAndrea Hayes-Jordan, Pete Anderson, Steven Curley, et al.
Plos One|August 15, 2014
Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumorsYunyun Jiang, Vivek Subbiah, Filip Janku, et al.
Pediatric Blood & Cancer|January 24, 2008
Multimodality treatment of osteosarcoma: radiation in a high-risk cohortAnita Mahajan, Shiao Y Woo, David G Kornguth, et al.
Current HIV/AIDS Reports|July 7, 2020
Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and PreventionPaul K Drain, Ashley R Bardon, Jane M Simoni, et al.
Frontiers in Pharmacology|May 7, 2019
Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and WomenMaria Pyra, Pete Anderson, Jessica E Haberer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumorsAung Naing, Patricia LoRusso, Siqing Fu, et al.
Oncotarget|October 30, 2015
Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicineVivek Subbiah, Michael J Wagner, Mary F McGuire, et al.
Oncotarget|August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trialsJ Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
Pageof 3